Streck adds instrument system to A1c control kit assay

Dec. 10, 2014

Streck's A1c-Cellular, a whole red blood cell A1c control with intact red blood cells, is now assayed for the Abbott ARCHITECT Integrated ci Systems. A1c-Cellular tests the entire HbA1c procedure, including the lysing of the red blood cell—a step omitted with other controls.

A1c-Cellular is also assayed for the Abbott ARCHITECT cSystems; Arkray Menarini ADAMS A1c HA-8160; Beckman Coulter UniCel DxC 600/800; Bio-Rad D-10/Variant II and Variant II Turbo; VITROS 5,1 FS/5600; cobas INTEGRA/6000/c311; Siemens Dimension Series; and Tosoh A1c 2.2 Plus/G7/G8.

Streck also offers A1c-Cellular Linearity, a Hemoglobin A1c (HbA1c) linearity/calibration verification material with intact red blood cells. A1c-Cellular Linearity is a five-level assayed linearity material used to assess instrument accuracy and verify the patient reportable range of the HbA1c parameter.

Streck's inter-laboratory quality control program, STATS, provides customers with evaluation of their instrument's performance against a peer group comprised of other labs using the same instrument, method, and product lot. The program is open to all customers at no charge. Streck's core technology is cell stabilization; product lines support the fields of hematology, immunology, and molecular biology.

Learn more on the Streck website